SEI Investments
DSGN icon

SEI Investments’s Design Therapeutics DSGN Stock Holding History

SEI Investments’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
22,740
-110,463
-83% -$1.38M ﹤0.01% 2822
2026
Q1 		$1.42M Buy
133,203
+80,473
+153% +$814K ﹤0.01% 2180
2025
Q4 		$495K Buy
+52,730
New +$413K ﹤0.01% 2510

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SEI Investments's DSGN Position: Q2 2026 in Review

SEI Investments reduced its Design Therapeutics (DSGN) stake by 83% in Q2 2026, selling an estimated $1.38M and leaving 22,740 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2822.

SEI Investments first reported a position in DSGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.42M in Q1 2026. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • SEI Investments held 22,740 shares of Design Therapeutics worth $329K as of Q2 2026.
  • SEI Investments sold 110,463 Design Therapeutics shares in Q2 2026, an estimated $1.38M.
  • Design Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2822 holding.
  • SEI Investments first reported a position in Design Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • SEI Investments's Design Therapeutics position peaked at $1.42M in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.